Sign in

CIK 0001477845 · Non-accelerated filer<br>Smaller reporting company

Annovis Bio, Inc.

Sign in to watch
Ticker
ANVS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
262540421
Phone
484-875-3192
Business address
101 LINDENWOOD DRIVE, SUITE 225, MALVERN, PA, 19355
Former names
QR Pharma, Inc.
  1. EFFECT Other Notice of Effectiveness
  2. CORRESP Other Correspondence Between Filers and SEC Staff
  3. UPLOAD Other SEC-generated Letter
  4. S-3 Offering Registration Statement
  5. SC 13G/A Stake Amended Statement of Ownership
  6. 10-Q Report Quarterly Report
  7. 10-Q Report Quarterly Report
  8. SC 13G Stake Amended Statement of Ownership
  9. SC 13G/A Stake Amended Statement of Ownership
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4/A Derivatives Options or other derivatives
  14. 8-K Event Regulation FD disclosure
  15. 8-K Event Shareholder vote results
  16. DEFA14A Proxy Proxy Materials
  17. 10-Q Report Quarterly Report
  18. DEF 14A Proxy Proxy Statement
  19. SC 13D Stake Beneficial Ownership Report
  20. 4 Derivatives Options or other derivatives

Page 13 of 16 · 315 filings